Bridgeway Capital Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $52,500 - $229,250	-175,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.61 - $1.84 $106,750 - $322,000	175,000 New	175,000 $242,000
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $600,927 - $1.38 Million	-156,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.57 - $6.58 $67,473 - $124,362	18,900 Added 13.7%	156,900 $597,000
Q1 2019 May 15, 2019	BUY	$5.19 - $8.97 $275,070 - $475,410	53,000 Added 62.35%	138,000 $1.14 Million
Q3 2018 Nov 13, 2018	BUY	$9.54 - $13.87 $810,899 - $1.18 Million	85,000 New	85,000 $839,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.08M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.